株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

API (原薬) の世界市場 - 2021年までの予測:革新的API、ジェネリックAPI

Active Pharmaceutical Ingredients/API Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, Rx), Therapy (Diabetes, Oncology, CNS, CVD) - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 225648
出版日 ページ情報 英文 315 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.34円で換算しております。
Back to Top
API (原薬) の世界市場 - 2021年までの予測:革新的API、ジェネリックAPI Active Pharmaceutical Ingredients/API Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, Rx), Therapy (Diabetes, Oncology, CNS, CVD) - Global Forecast to 2021
出版日: 2017年01月10日 ページ情報: 英文 315 Pages
概要

API (原薬) 市場は、2016年の1,579億5000万米ドルから、2021年までに2,139億7000万米ドルまで拡大すると見られています。市場は、2016年〜2021年のCAGR (複合年間成長率) で、6.3%の成長が予測されています。

当レポートでは、世界のAPI (原薬) 市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • API市場の概要
  • API市場:メーカータイプ別
  • API市場:治療領域別
  • バイオテクノロジーAPI市場:製品別
  • API市場:薬剤の種類別
  • API市場:地域別スナップショット

第5章 APIの世界市場:概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題

第6章 APIの世界市場:種類別

  • イントロダクション
  • 革新的API
  • ジェネリックAPI

第7章 APIの世界市場:メーカータイプ別

  • イントロダクション
  • キャプティブメーカー
  • マーチャントAPIメーカー

第8章 APIの世界市場:合成の種類別

  • イントロダクション
  • 合成API
  • バイオテクノロジーAPI

第9章 APIの世界市場:薬剤の種類別

  • イントロダクション
  • 処方薬
  • OTC薬
  • API市場:効能別

第10章 APIの世界市場:治療応用別

  • イントロダクション
  • 腫瘍
  • 心血管系疾患
  • 糖尿病
  • 中枢神経系・神経学的障害
  • 内分泌系
  • その他

第11章 APIの世界市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他

第12章 競合情勢

  • イントロダクション
  • 市場企業ランキング
  • 競合状況と動向

第13章 企業プロファイル

  • イントロダクション
  • PFIZER, INC.
  • NOVARTIS INTERNATIONAL AG
  • SANOFI
  • BOEHRINGER INGELHEIM
  • BRISTOL-MYERS SQUIBB
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • ELI LILLY AND COMPANY
  • GLAXOSMITHKLINE PLC
  • MERCK & CO., INC.
  • ABBVIE INC.

第14章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PH 1262

The active pharmaceutical ingredients market in terms of value is expected to reach USD 213.97 billion by 2021 from USD 157.95 billion in 2016, growing at a CAGR of 6.3% from 2016 to 2021. This market is categorized on the basis of type, type of manufacturer, type of synthesis, type of drug, therapeutic application, and region.

Major factors contributing to the growth of the active pharmaceutical ingredients market include increasing incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications (ANDA) and increasing uptake of biopharmaceuticals. Government initiatives to encourage adoption of generics also provide an impetus for the growth of this market. For instance, in 2008, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, launched the Jan Aushadhi Scheme (Public Medicine Scheme) for providing quality medicines to the masses at affordable prices. Under this initiative, the government set up Jan Aushadhi stores to provide generic drugs to patients. Similarly, The European Union's decentralized procedure (DCP) for drug approval is an effective system for cross-border collaboration on the authorization of medicines. This is being used as a model for a number of new global initiatives in the harmonization of pharmaceutical regulatory standards. The implementation of such standards in turn is expected to drive the adoption of generic drugs.

Emerging biosimilars market, increasing scope for HPAPIs, emerging markets and emerging technologies have opened an array of opportunities for the active pharmaceutical ingredients market. However, factors such as a stringent regulatory requirements and unfavorable drug price control policies across various countries may restrain the growth of this market.

Based on type, the market is segmented into innovative and generic APIs. On the basis of type of manufacture, the APIs market is categorized into two segments, captive manufacturer and merchant manufacturer. On the basis of type of synthesis, the APIs market is segmented into synthetic APIs and biotech APIs. On the basis of type of drug, the APIs market is segmented into prescription and over-the-counter APIs. On the basis of therapeutic application, the APIs market is further segmented into oncology, cardiovascular diseases, diabetes, endocrinology, central nervous system and neurological diseases and other therapeutic applications.

Research Coverage:

Apart from the comprehensive geographical and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the active pharmaceutical ingredients market and their product portfolios, developments, and strategies. The above-mentioned market research data, current market size, and forecast of the future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of top players in the active pharmaceutical ingredients market. The report analyzes the active pharmaceutical ingredients market by application, sales channel, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the active pharmaceutical ingredients market
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the active pharmaceutical ingredients market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various active pharmaceutical ingredients products across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the active pharmaceutical ingredients market

Table of Contents

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. STUDY SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. KEY DATA FROM SECONDARY SOURCES
  • 2.4. KEY DATA FROM PRIMARY SOURCES
  • 2.5. KEY INDUSTRY INSIGHTS
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET OVERVIEW
  • 4.2. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER
  • 4.3. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC AREA
  • 4.4. BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT
  • 4.5. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG
  • 4.6. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: GEOGRAPHIC SNAPSHOT

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing incidence of chronic diseases
      • 5.2.1.2. Rising prevalence of cancer
      • 5.2.1.3. Technological advancements in API manufacturing
      • 5.2.1.4. Growing importance of generics
      • 5.2.1.5. Rapidly increasing geriatric population
      • 5.2.1.6. Increase in abbreviated new drug applications (ANDA)
      • 5.2.1.7. Increasing uptake of biopharmaceuticals
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Stringent regulatory requirements
      • 5.2.2.2. Unfavorable drug price control policies across various countries
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging biosimilars market
      • 5.2.3.2. Increasing scope for high-potency active pharmaceutical ingredients
      • 5.2.3.3. Emerging markets
      • 5.2.3.4. Emerging technologies
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Product differentiation
      • 5.2.4.2. High manufacturing costs

6. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS
  • 6.3. GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS

7. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER

  • 7.1. INTRODUCTION
  • 7.2. CAPTIVE MANUFACTURERS
  • 7.3. MERCHANT API MANUFACTURERS
    • 7.3.1. MERCHANT MANUFACTURERS MARKET, BY TYPE
      • 7.3.1.1. Innovative merchant API manufacturers
      • 7.3.1.2. Generic merchant API manufacturers
    • 7.3.2. MERCHANT API MANUFACTURERS MARKET, BY MODE OF SYNTHESIS
      • 7.3.2.1. Synthetic APIs
      • 7.3.2.2. Biotech APIs

8. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS

  • 8.1. INTRODUCTION
  • 8.2. SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS
    • 8.2.1. SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
      • 8.2.1.1. Innovative synthetic APIs
      • 8.2.1.2. Generic synthetic APIs
  • 8.3. BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS
    • 8.3.1. BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
      • 8.3.1.1. Innovative biotech APIs
      • 8.3.1.2. Biosimilars
    • 8.3.2. BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT
      • 8.3.2.1. Monoclonal antibodies
      • 8.3.2.2. Vaccines
      • 8.3.2.3. Hormones and growth factors
      • 8.3.2.4. Cytokines
      • 8.3.2.5. Fusion proteins
      • 8.3.2.6. Therapeutic enzymes
      • 8.3.2.7. Blood factors
    • 8.3.3. BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM
      • 8.3.3.1. Mammalian expression systems
      • 8.3.3.2. Microbial expression systems
      • 8.3.3.3. Yeast expression systems
      • 8.3.3.4. Plant expression systems
      • 8.3.3.5. Insect expression systems

9. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG

  • 9.1. INTRODUCTION
  • 9.2. PRESCRIPTION DRUGS
  • 9.3. OVER-THE-COUNTER DRUGS
  • 9.4. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY
    • 9.4.1. LOW TO MODERATE POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS
    • 9.4.2. POTENT TO HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS

10. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION

  • 10.1. INTRODUCTION
  • 10.2. ONCOLOGY
  • 10.3. CARDIOVASCULAR DISEASE
  • 10.4. DIABETES
  • 10.5. CENTRAL NERVOUS SYSTEM AND NEUROLOGICAL DISORDERS
  • 10.6. ENDOCRINOLOGY
  • 10.7. OTHER THERAPEUTIC APPLICATIONS

11. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. FRANCE
    • 11.3.3. U.K.
    • 11.3.4. ITALY
    • 11.3.5. SPAIN
    • 11.3.6. REST OF EUROPE (ROE)
  • 11.4. ASIA
    • 11.4.1. JAPAN
    • 11.4.2. CHINA
    • 11.4.3. INDIA
    • 11.4.4. SOUTH KOREA
    • 11.4.5. REST OF ASIA (ROA)
  • 11.5. REST OF THE WORLD (ROW)

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET PLAYER RANKING
  • 12.3. COMPETITIVE SITUATION AND TRENDS
    • 12.3.1. AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, JOINT VENTURES, AND ALLIANCES
    • 12.3.2. REGULATORY APPROVALS
    • 12.3.3. MERGERS AND ACQUISITIONS
    • 12.3.4. EXPANSIONS
    • 12.3.5. INVESTMENTS

13. COMPANY PROFILES (Company at a Glance, Business Overview, Products Offered, Key Strategy, Recent Developments, SWOT Analysis & MNM View)*

  • 13.1. INTRODUCTION
  • 13.2. PFIZER, INC.
  • 13.3. NOVARTIS INTERNATIONAL AG
  • 13.4. SANOFI
  • 13.5. BOEHRINGER INGELHEIM
  • 13.6. BRISTOL-MYERS SQUIBB
  • 13.7. TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • 13.8. ELI LILLY AND COMPANY
  • 13.9. GLAXOSMITHKLINE PLC
  • 13.1. MERCK & CO., INC.
  • 13.11. ABBVIE INC.

*Details on company at a glance, recent financials, Products offered, strategies & insights, & recent developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. OTHER DEVELOPMENTS
  • 14.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.5. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.6. AVAILABLE CUSTOMIZATIONS
  • 14.7. RELATED REPORTS
  • 14.8. AUTHOR DETAILS

List Of Tables:

  • TABLE 1: INDICATIVE LIST OF GENERIC DRUGS THAT GAINED APPROVAL IN 2016
  • TABLE 2: STATISTICS ON AGING POPULATION
  • TABLE 3: INDICATIVE LIST OF BIOLOGICS THAT GAINED U.S. REGULATORY APPROVALIN 2015-2016
  • TABLE 4: INCREASING INCIDENCE OF CHRONIC DISEASES: A MAJOR MARKET DRIVER
  • TABLE 5: STRINGENT REGULATORY REQUIREMENTS: A MAJOR RESTRAINT FOR MARKET GROWTH
  • TABLE 6: EMERGING MARKETS OFFER SIGNIFICANT GROWTH OPPORTUNITIES
  • TABLE 7: STRINGENT REGULATORY GUIDELINES: A MAJOR CHALLENGE FOR MARKET GROWTH
  • TABLE 8: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE,2014-2021 (USD BILLION)
  • TABLE 9: INDICATIVE LIST OF NEW MOLECULAR ENTITIES THAT GAINED U.S. FDA APPROVAL IN 2016
  • TABLE 10: SIGNIFICANT PATENT EXPIRIES, 2015
  • TABLE 11: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 12: NORTH AMERICA: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 13: EUROPE: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 14: ASIA: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 15: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION,2014-2021 (USD BILLION)
  • TABLE 16: NORTH AMERICA: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 17: EUROPE: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 18: ASIA: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 19: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 20: CAPTIVE API MANUFACTURERS MARKET SIZE, BY REGION,2014-2021 (USD BILLION)
  • TABLE 21: NORTH AMERICA: CAPTIVE API MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 22: EUROPE: CAPTIVE API MANUFACTURERS MARKET SIZE, BY COUNTRY,2014-2021 (USD BILLION)
  • TABLE 23: ASIA: CAPTIVE API MANUFACTURERS MARKET SIZE, BY COUNTRY,2014-2021 (USD BILLION)
  • TABLE 24: LIST OF SIGNIFICANT MERGERS AND ACQUISITIONS IN THE CMO/CDMO INDUSTRY
  • TABLE 25: LIST OF SIGNIFICANT CMO/CDMO FACILITY EXPANSIONS
  • TABLE 26: MERCHANT API MANUFACTURERS MARKET SIZE, BY REGION,2014-2021 (USD BILLION)
  • TABLE 27: NORTH AMERICA: MERCHANT API MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 28: EUROPE: MERCHANT API MANUFACTURERS MARKET SIZE, BY COUNTRY,2014-2021 (USD BILLION)
  • TABLE 29: ASIA: MERCHANT API MANUFACTURERS MARKET SIZE, BY COUNTRY,2014-2021 (USD BILLION)
  • TABLE 30: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE,2014-2021 (USD BILLION)
  • TABLE 31: INNOVATIVE MERCHANT API MANUFACTURERS MARKET SIZE, BY REGION,2014-2021 (USD BILLION)
  • TABLE 32: NORTH AMERICA: INNOVATIVE MERCHANT API MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 33: EUROPE: INNOVATIVE MERCHANT API MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 34: ASIA: INNOVATIVE MERCHANT API MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 35: GENERIC MERCHANT API MANUFACTURERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 36: NORTH AMERICA: GENERIC MERCHANT API MANUFACTURERS MARKET SIZE,BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 37: EUROPE: GENERIC MERCHANT API MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 38: ASIA: GENERIC MERCHANT API MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 39: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS,2014-2021 (USD BILLION)
  • TABLE 40: MERCHANT SYNTHETIC API MANUFACTURERS MARKET SIZE, BY REGION,2014-2021 (USD BILLION)
  • TABLE 41: NORTH AMERICA: MERCHANT SYNTHETIC API MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 42: EUROPE: MERCHANT SYNTHETIC API MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 43: ASIA: MERCHANT SYNTHETIC API MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 44: MERCHANT BIOTECH API MANUFACTURERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 45: NORTH AMERICA: MERCHANT BIOTECH API MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 46: EUROPE: MERCHANT BIOTECH API MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 47: ASIA: MERCHANT BIOTECH API MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 48: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 49: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 50: NORTH AMERICA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 51: EUROPE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 52: ASIA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 53: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 54: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 55: NORTH AMERICA: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 56: EUROPE: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 57: ASIA: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 58: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 59: NORTH AMERICA: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 60: EUROPE: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 61: ASIA: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 62: TOP SELLING BIOLOGICS (2015)
  • TABLE 63: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 64: NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 65: EUROPE: BIOTECH PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 66: ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 67: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 68: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 69: NORTH AMERICA: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 70: EUROPE: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 71: ASIA: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 72: BIOSIMILARS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 73: NORTH AMERICA: BIOSIMILARS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 74: EUROPE: BIOSIMILARS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 75: ASIA: BIOSIMILARS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 76: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 77: INDICATIVE LIST OF MONOCLONAL ANTIBODIES THAT RECEIVED FDA APPROVAL IN 2016
  • TABLE 78: MONOCLONAL ANTIBODIES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 79: NORTH AMERICA: MONOCLONAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 80: EUROPE: MONOCLONAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 81: ASIA: MONOCLONAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 82: VACCINES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 83: NORTH AMERICA: VACCINES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 84: EUROPE: VACCINES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 85: ASIA: VACCINES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 86: HORMONES AND GROWTH FACTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 87: NORTH AMERICA: HORMONES AND GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 88: EUROPE: HORMONES AND GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 89: ASIA: HORMONES AND GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 90: CYTOKINES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 91: NORTH AMERICA: CYTOKINES MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 92: EUROPE: CYTOKINES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 93: ASIA: CYTOKINES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 94: FUSION PROTEINS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 95: NORTH AMERICA: FUSION PROTEINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 96: EUROPE: FUSION PROTEINS MARKET SIZE, BY COUNTRY,2014-2021 (USD MILLION)
  • TABLE 97: ASIA: FUSION PROTEINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 98: THERAPEUTIC ENZYMES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 99: NORTH AMERICA: THERAPEUTIC ENZYMES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 100: EUROPE: THERAPEUTIC ENZYMES MARKET SIZE, BY COUNTRY,2014-2021 (USD MILLION)
  • TABLE 101: ASIA: MERCHANT THERAPEUTIC ENZYMES MARKET SIZE, BY COUNTRY,2014-2021 (USD MILLION)
  • TABLE 102: BLOOD FACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 103: NORTH AMERICA: BLOOD FACTORS MARKET SIZE, BY COUNTRY,2014-2021 (USD MILLION)
  • TABLE 104: EUROPE: BLOOD FACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 105: ASIA: BLOOD FACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 106: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY EXPRESSION SYSTEM, 2014-2021 (USD BILLION)
  • TABLE 107: MAMMALIAN EXPRESSION SYSTEMS MARKET SIZE, BY REGION,2014-2021 (USD BILLION)
  • TABLE 108: NORTH AMERICA: MAMMALIAN EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 109: EUROPE: MAMMALIAN EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY,2014-2021 (USD BILLION)
  • TABLE 110: ASIA: MAMMALIAN EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY,2014-2021 (USD BILLION)
  • TABLE 111: MICROBIAL EXPRESSION SYSTEMS MARKET SIZE, BY REGION,2014-2021 (USD BILLION)
  • TABLE 112: NORTH AMERICA: MICROBIAL EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 113: EUROPE: MICROBIAL EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY,2014-2021 (USD BILLION)
  • TABLE 114: ASIA: MICROBIAL EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY,2014-2021 (USD BILLION)
  • TABLE 115: YEAST EXPRESSION SYSTEMS MARKET SIZE, BY REGION,2014-2021 (USD BILLION)
  • TABLE 116: NORTH AMERICA: YEAST EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY,2014-2021 (USD BILLION)
  • TABLE 117: EUROPE: YEAST EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY,2014-2021 (USD BILLION)
  • TABLE 118: ASIA: YEAST EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY,2014-2021 (USD BILLION)
  • TABLE 119: PLANT EXPRESSION SYSTEMS MARKET SIZE, BY REGION,2014-2021 (USD BILLION)
  • TABLE 120: NORTH AMERICA: PLANT EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 121: EUROPE: PLANT EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY,2014-2021 (USD MILLION)
  • TABLE 122: ASIA: OTHER EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY,2014-2021 (USD MILLION)
  • TABLE 123: INSECT EXPRESSION SYSTEMS MARKET SIZE, BY REGION,2014-2021 (USD BILLION)
  • TABLE 124: NORTH AMERICA: INSECT EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 125: EUROPE: INSECT EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY,2014-2021 (USD MILLION)
  • TABLE 126: ASIA: INSECT EXPRESSION SYSTEMS MARKET SIZE, BY COUNTRY,2014-2021 (USD MILLION)
  • TABLE 127: GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 128: GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR PRESCRIPTION DRUGS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 129: NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR PRESCRIPTION DRUGS, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 130: EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR PRESCRIPTION DRUGS, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 131: ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR PRESCRIPTION DRUGS, COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 132: PRESCRIPTION-TO-OTC SWITCH LIST IN THE U.S.
  • TABLE 133: GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR OVER-THE-COUNTER DRUGS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 134: NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR OVER-THE-COUNTER DRUGS, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 135: EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR OVER-THE-COUNTER DRUGS, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 136: ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR OVER-THE-COUNTER DRUGS, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 137: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY POTENCY, 2014-2021 (USD BILLION)
  • TABLE 138: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 139: CANCER: ESTIMATED INCIDENCE, MORTALITY, AND PREVALENCE (2012)
  • TABLE 140: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR ONCOLOGY, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 141: NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR ONCOLOGY, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 142: EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR ONCOLOGY, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 143: ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR ONCOLOGY, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 144: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR CVD, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 145: NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR CVD, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 146: EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR CVD, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 147: ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR CVD, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 148: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR DIABETES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 149: NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR DIABETES, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 150: EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR DIABETES, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 151: ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR DIABETES, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 152: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR CNS AND NEUROLOGICAL DISORDERS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 153: NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR CNS AND NEUROLOGICAL DISORDERS, BY COUNTRY, 2014-2021 (USD BILLION 160
  • TABLE 154: EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR CNS AND NEUROLOGICAL DISORDERS, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 155: ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR CNS AND NEUROLOGICAL DISORDERS, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 156: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR ENDOCRINOLOGY, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 157: NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR ENDOCRINOLOGY, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 158: EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR ENDOCRINOLOGY, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 159: ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR ENDOCRINOLOGY, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 160: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 161: NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 162: EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 163: ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 164: GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 165: NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 166: NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 167: NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 168: NORTH AMERICA: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 169: NORTH AMERICA: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 170: NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 171: NORTH AMERICA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 172: NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 173: NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 174: NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD BILLION)
  • TABLE 175: NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 176: NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 177: RECENT FDA APPROVALS FOR NDA AND ANDA
  • TABLE 178: U.S.: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 179: U.S.: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 180: U.S.: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 181: U.S.: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 182: U.S.: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 183: U.S.: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 184: U.S.: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 185: U.S.: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 186: U.S.: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD BILLION)
  • TABLE 187: U.S.: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 188: U.S.: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 189: CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 190: CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 191: CANADA: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 192: CANADA: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 193: CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 194: CANADA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 195: CANADA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 196: CANADA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 197: CANADA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD BILLION)
  • TABLE 198: CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 199: CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 200: EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 201: EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 202: EUROPE: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 203: EUROPE: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 204: EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 205: EUROPE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 206: EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 207: EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 208: EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD BILLION)
  • TABLE 209: EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 210: EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 211: GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 212: GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 213: GERMANY: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 214: GERMANY: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 215: GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 216: GERMANY: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 217: GERMANY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 218: GERMANY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 219: GERMANY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD BILLION)
  • TABLE 220: GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 221: GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 222: FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 223: FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 224: FRANCE: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 225: FRANCE: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 226: FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 227: FRANCE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 228: FRANCE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 229: FRANCE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 230: FRANCE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD BILLION)
  • TABLE 231: FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 232: FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 233: U.K.: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 234: U.K.: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 235: U.K.: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 236: U.K.: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 237: U.K.: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 238: U.K.: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 239: U.K.: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 240: U.K.: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 241: U.K.: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 242: U.K.: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 243: U.K.: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 244: ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 245: ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 246: ITALY: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 247: ITALY: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 248: ITALIAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 249: ITALY: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 250: ITALY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 251: ITALY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 252: ITALY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 253: ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 254: ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 255: SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 256: SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 257: SPAIN: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 258: SPAIN: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 259: SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 260: SPAIN: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 261: SPAIN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 262: SPAIN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 263: SPAIN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 264: SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 265: SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 266: ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 267: ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 268: ROE: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 269: ROE: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 270: ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 271: ROE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 272: ROE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 273: ROE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 274: ROE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 275: ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 276: ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 277: ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 278: ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 279: ASIA: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 280: ASIA: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 281: ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 282: ASIA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 283: ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 284: ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 285: ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD BILLION)
  • TABLE 286: ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 287: ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 288: JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 289: JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 290: JAPAN: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 291: JAPAN: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 292: JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 293: JAPAN: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 294: JAPAN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 295: JAPAN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 296: JAPAN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 297: JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 298: JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 299: CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 300: CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 301: CHINA: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 302: CHINA: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 303: CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 304: CHINA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 305: CHINA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 306: CHINA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 307: CHINA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 308: CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 309: CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 310: INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 311: INDIAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 312: INDIA: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 313: INDIA: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 314: INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 315: INDIA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 316: INDIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 317: INDIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 318: INDIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 319: INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 320: INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 321: SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 322: SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 323: SOUTH KOREA: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 324: SOUTH KOREA: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 325: SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 326: SOUTH KOREA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 327: SOUTH KOREA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 328: SOUTH KOREA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 329: SOUTH KOREA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 330: SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 331: SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 332: ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 333: ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 334: ROA: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 335: ROA: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 336: ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 337: ROA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 338: ROA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 339: ROA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 340: ROA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD MILLION)
  • TABLE 341: ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 342: ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 343: ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 344: ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD BILLION)
  • TABLE 345: ROW: MERCHANT API MANUFACTURERS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 346: ROW: MERCHANT API MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 347: ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD BILLION)
  • TABLE 348: ROW: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 349: ROW: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 350: ROW: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 351: ROW: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF EXPRESSION SYSTEM, 2014-2021 (USD BILLION)
  • TABLE 352: ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF DRUG, 2014-2021 (USD BILLION)
  • TABLE 353: ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 354: AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, JOINT VENTURES, AND ALLIANCES (2013-2016)
  • TABLE 355: REGULATORY APPROVALS (2013-2016)
  • TABLE 356: MERGERS AND ACQUISITIONS (2013-2016)
  • TABLE 357: EXPANSIONS (2013-2016)
  • TABLE 358: INVESTMENTS (2013-2016)
  • TABLE 359: EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF EUR TO USD)
  • TABLE 360: EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF GBP TO USD)
  • TABLE 361: PFIZER INC. (U.S.)
  • TABLE 362: NOVARTIS INTERNATIONAL AG (SWITZERLAND)
  • TABLE 363: SANOFI (FRANCE)
  • TABLE 364: BOEHRINGER INGELHEIM (GERMANY)
  • TABLE 365: BRISTOL-MYERS SQUIBB (U.S.)
  • TABLE 366: TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
  • TABLE 367: GLAXOSMITHKLINE PLC (U.K.)
  • TABLE 368: MERCK & CO., INC. (U.S.)
  • TABLE 369: ABBVIE (U.S.)

List Of Figures:

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2016 VS. 2021
  • FIGURE 7: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2016 VS. 2021
  • FIGURE 8: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS, 2016 VS. 2021
  • FIGURE 9: BIOTECH ACTIVE PHARMACEUTICALS INGREDIENTS MARKET SIZE, BY PRODUCT: MONOCLONAL ANTIBODIES TO DOMINATE THE MARKET IN 2016
  • FIGURE 10: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016 VS. 2021
  • FIGURE 11: GEOGRAPHIC SNAPSHOT OF THE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
  • FIGURE 12: GROWING IMPORTANCE OF GENERICS, THE MAJOR FACTOR DRIVING THE GROWTH OF THE MARKET
  • FIGURE 13: CAPTIVE MANUFACTURERS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
  • FIGURE 14: ONCOLOGY SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: MONOCLONAL ANTIBODIES SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: OVER-THE-COUNTER DRUGS TO WITNESS HIGHEST GROWTH FROM 2016-2021
  • FIGURE 17: ASIA TO WITNESS HIGHEST GROWTH IN THE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: INNOVATIVE SEGMENT TO DOMINATE THE MARKET IN 2016
  • FIGURE 20: CAPTIVE MANUFACTURERS TO DOMINATE THE MARKET IN 2016
  • FIGURE 21: NORTH AMERICA TO DOMINATE THE MARKET FOR CAPTIVE MANUFACTURERSIN 2016
  • FIGURE 22: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS SEGMENT TO DOMINATE THE MARKET IN 2016
  • FIGURE 23: NORTH AMERICA TO DOMINATE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET IN 2016
  • FIGURE 24: PRESCRIPTION DRUGS TO DOMINATE THE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, IN 2016
  • FIGURE 25: LOW TO MODERATE SEGMENT TO DOMINATE THE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, IN 2016
  • FIGURE 26: ONCOLOGY SEGMENT TO DOMINATE THE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION
  • FIGURE 27: NORTH AMERICA TO DOMINATE THE ONCOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION
  • FIGURE 28: ASIA TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD (2016-2021)
  • FIGURE 29: NORTH AMERICA TO HOLD THE LARGEST SHARE OF THE GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET (2016)
  • FIGURE 30: EUROPEAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SNAPSHOT (2016)
  • FIGURE 31: ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SNAPSHOT (2016)
  • FIGURE 32: ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SNAPSHOT
  • FIGURE 33: KEY DEVELOPMENTS IN THE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, 2013-2016
  • FIGURE 34: MARKET EVOLUTION FRAMEWORK-AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES, AND ALLIANCES FUELED MARKET GROWTH
  • FIGURE 35: BATTLE FOR MARKET SHARE: AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES, AND ALLIANCES WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS 2013- 2016)
  • FIGURE 36: GEOGRAPHIC MIX OF THE TOP 5 PLAYERS
  • FIGURE 37: PFIZER, INC.: COMPANY SNAPSHOT
  • FIGURE 38: NOVARTIS INTERNATIONAL AG: COMPANY SNAPSHOT
  • FIGURE 39: SANOFI: COMPANY SNAPSHOT
  • FIGURE 40: BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
  • FIGURE 41: BRISTOL-MYERS SQUIBB: COMPANY SNAPSHOT
  • FIGURE 42: TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
  • FIGURE 43: ELI LILLY AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 44: GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
  • FIGURE 45: MERCK & CO., INC.: COMPANY SNAPSHOT
  • FIGURE 46: ABBVIE INC.: COMPANY SNAPSHOT
Back to Top